CAPRICOR THERAPEUTICS, INC. — Investor Relations & Filings
Filings indexed
919
across all filing types
Latest filing
2026-01-07
Director's Dealing
Country
US
United States of America
Listing
US
CAPR
Capricor Therapeutics is a clinical-stage biotechnology company focused on the development of biologics, primarily cell and exosome-based technologies. The company's science is centered on its proprietary platform of allogeneic cardiosphere-derived cells (CDCs) and engineered exosomes to create novel therapeutics. Its lead candidate, Deramiocel (CAP-1002), is a cell therapy that has completed a pivotal Phase 3 study for the treatment of Duchenne muscular dystrophy (DMD). Capricor's pipeline leverages its core technologies to treat or prevent a broad range of serious diseases with significant unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 4 Filing | 2026-01-07 | English | |
| Director's Dealing 2025 | 2025-12-23 | English | |
| 424B5 | 2025-12-05 | English | |
| 8-K | 2025-12-05 | English | |
| 424B3 | 2025-12-05 | English | |
| 424B5 | 2025-12-04 | English |
Browse filings by year
26 years- 2026 16 filings
- 2025 47 filings
- 2024 57 filings
- 2023 56 filings
- 2022 33 filings
- 2021 35 filings
- 2020 47 filings
- 2019 52 filings
- 2018 34 filings
- 2017 58 filings
- 2016 59 filings
- 2015 69 filings
- 2014 39 filings
- 2013 39 filings
- 2012 23 filings
- 2011 37 filings
- 2010 44 filings
- 2009 50 filings
- 2008 46 filings
- 2007 31 filings
- 2006 20 filings
- 2005 6 filings
- 2004 5 filings
- 2003 6 filings
- 2002 6 filings
- 2001 4 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
1 filing
| |||||
| 28106021 | 4 Filing | 2026-01-07 | English | ||
|
2025
14 filings
| |||||
| 11424093 | Director's Dealing 2025 | 2025-12-23 | English | ||
| 11424094 | 424B5 | 2025-12-05 | English | ||
| 11424095 | 8-K | 2025-12-05 | English | ||
| 11424096 | 424B3 | 2025-12-05 | English | ||
| 11424097 | 424B5 | 2025-12-04 | English | ||
| 11424099 | 8-K | 2025-12-03 | English | ||
| 11424098 | 8-K | 2025-12-03 | English | ||
| 11424100 | 10-Q | 2025-11-10 | English | ||
| 11424101 | 8-K | 2025-11-10 | English | ||
| 11424102 | Major Shareholding Notification 2025 | 2025-10-30 | English | ||
| 11424103 | Regulatory Filings 2025 | 2025-09-24 | English | ||
| 11424104 | S-3 | 2025-09-10 | English | ||
| 11424106 | 10-Q | 2025-08-11 | English | ||
| 11424105 | 8-K | 2025-08-11 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
CAPRICOR THERAPEUTICS, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33192/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33192 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33192 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33192 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33192}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CAPRICOR THERAPEUTICS, INC. (id: 33192)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.